Belief BioMed (BBM) and Takeda China have announced China’s National Medical Products Administration's (NMPA) approval for ...

Biocon Biologics CEO and managing director Shreehas Tambe stated: “The US FDA approval of Jobevne (bevacizumab-nwgd) is a ...

Following the firm’s $1.75bn acquisition of radiopharmaceuticals company Mariana Oncology and the $745m deal with Ratio ...

The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.

Pluri has announced the issuance of a patent by the US Patent and Trademark Office (USPTO) for its immune cell expansion ...

On 7 April, at the 2025 American Academy of Neurology (AAN) meeting, a poster presentation by the Peking Union Medical ...

The UK's MHRA has been redesignated as one of the WHO’s collaborating centres for the standardisation and evaluation of ...

AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.

PharmaLogic is set to acquire a majority stake in Agilera Pharma to generate the CDMO focusing on radiopharmaceutical ...

The biotech has launched a strategic review to consider options, including a possible sale, following shareholder pressure.

The Inflation Reduction Act (IRA) is expected to influence the clinical development strategies of pharma companies profoundly ...